Published in J Clin Endocrinol Metab on November 01, 2015
Use of Antibiotics and Risk of Type 2 Diabetes: A Population-Based Case-Control Study. J Clin Endocrinol Metab (2015) 2.82
Letter to the Editor: Epidemiologic Association Between Antibiotic Use With the Risk of Developing Type 2 Diabetes Mellitus. J Clin Endocrinol Metab (2015) 1.07
The Danish National Prescription Registry. Scand J Public Health (2011) 6.07
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ (2012) 5.57
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med (2007) 2.85
Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease. Kidney Int (2013) 2.08
Impaired regulation of the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab (2011) 1.90
Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke (2002) 1.86
Persistence of antimuscarinic drug use. Eur J Clin Pharmacol (2008) 1.80
Incidence rate of community-acquired sepsis among hospitalized acute medical patients-a population-based survey. Crit Care Med (2015) 1.75
Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study. Stroke (2003) 1.74
The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans. J Appl Physiol (1985) (2007) 1.71
Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans. Diabetes (2011) 1.63
Assessment of gene-by-sex interaction effect on bone mineral density. J Bone Miner Res (2012) 1.58
Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects. J Clin Endocrinol Metab (2012) 1.49
Hormone replacement therapy increases the risk of cranial meningioma. Eur J Cancer (2013) 1.47
The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease. Thromb Haemost (2005) 1.46
2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab (2011) 1.44
The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action. Diabetes (2010) 1.43
Children's relative age in class and use of medication for ADHD: a Danish Nationwide Study. J Child Psychol Psychiatry (2014) 1.41
First trimester in utero exposure to methylphenidate. Basic Clin Pharmacol Toxicol (2013) 1.38
Risk scoring systems for adults admitted to the emergency department: a systematic review. Scand J Trauma Resusc Emerg Med (2010) 1.34
Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study. Br J Clin Pharmacol (2013) 1.32
Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol (2006) 1.28
The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand (2004) 1.19
Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care (2011) 1.17
Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med (2013) 1.16
Prevalence, awareness, and control of arterial hypertension in Denmark. J Am Soc Hypertens (2008) 1.11
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes. Am J Physiol Endocrinol Metab (2011) 1.10
Lixisenatide for type 2 diabetes mellitus. Expert Opin Investig Drugs (2011) 1.09
Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016;65:585-597. Diabetes (2016) 1.09
Nurse tele-consultations with discharged COPD patients reduce early readmissions--an interventional study. Clin Respir J (2011) 1.09
Annotations and reflections: pregnancy and paracetamol: methodological considerations on the study of associations between in utero exposure to drugs and childhood neurodevelopment. Basic Clin Pharmacol Toxicol (2014) 1.07
Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer. Expert Opin Drug Saf (2014) 1.06
Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients. Gynecol Oncol (2012) 1.06
Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus. J Clin Endocrinol Metab (2009) 1.06
Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf (2009) 1.03
Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans. Eur J Endocrinol (2014) 1.03
The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective. Eur J Clin Pharmacol (2012) 1.03
Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study. Am J Gastroenterol (2006) 1.03
An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2009) 1.01
Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes. Am J Physiol Endocrinol Metab (2010) 1.00
Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med (2014) 1.00
The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty. Am J Physiol Gastrointest Liver Physiol (2013) 1.00
Alcohol and breastfeeding. Basic Clin Pharmacol Toxicol (2013) 0.99
Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? Diabetologia (2014) 0.98
Characteristics of undertreatment in COPD in the general population. Chest (2013) 0.97
The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective. Eur J Clin Pharmacol (2012) 0.97
Treatment failures after antibiotic therapy of uncomplicated urinary tract infections. A prescription database study. Scand J Prim Health Care (2002) 0.95
Short- and long-term mortality in patients with community-acquired severe sepsis and septic shock. Scand J Infect Dis (2013) 0.95
Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study. Epilepsia (2008) 0.94
The risk of missed gastroesophageal cancer diagnoses in users and nonusers of antisecretory medication. Gastroenterology (2005) 0.94
Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study. Eur J Clin Pharmacol (2007) 0.92
Pharmaceutical interventions on prescription problems in a Danish pharmacy setting. Int J Clin Pharm (2011) 0.92
Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus. IDrugs (2009) 0.92
The alpha-cell as target for type 2 diabetes therapy. Rev Diabet Stud (2011) 0.91
Epigenetic signature of birth weight discordance in adult twins. BMC Genomics (2014) 0.91
Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data. Eur J Clin Pharmacol (2012) 0.90
Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies. Diabetes Care (2013) 0.90
Once-weekly GLP-1 agonists: How do they differ from exenatide and liraglutide? Curr Diab Rep (2010) 0.90
Use of SSRIs among Danish children: a nationwide study. Eur Child Adolesc Psychiatry (2014) 0.90
Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans. J Clin Endocrinol Metab (2014) 0.89
Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes. J Clin Endocrinol Metab (2013) 0.87
A MiniReview of the use of hospital-based databases in observational inpatient studies of drugs. Basic Clin Pharmacol Toxicol (2012) 0.87
Type of hormone therapy and risk of misclassification at mammography screening. Menopause (2011) 0.87
Glucagon and type 2 diabetes: the return of the alpha cell. Curr Diab Rep (2014) 0.87
Use of opioids in a Danish population-based cohort of cancer patients. J Pain Symptom Manage (2005) 0.86
Gastric bypass surgery: improving psoriasis through a GLP-1-dependent mechanism? Med Hypotheses (2011) 0.86
Cancer risk in long-term users of vitamin K antagonists: a population-based case-control study. Int J Cancer (2012) 0.86
Assigning exposure duration to single prescriptions by use of the waiting time distribution. Pharmacoepidemiol Drug Saf (2013) 0.85
Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study. Cancer Med (2014) 0.85
The spectrum of antidiabetic actions of GLP-1 in patients with diabetes. Best Pract Res Clin Endocrinol Metab (2009) 0.84
Cardiovascular drugs and the risk of suicide: a nested case-control study. Eur J Clin Pharmacol (2007) 0.84
[Danish drug consumption trends]. Ugeskr Laeger (2009) 0.84
First-trimester exposure to methylphenidate: a population-based cohort study. J Clin Psychiatry (2014) 0.84
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients. Am J Physiol Gastrointest Liver Physiol (2012) 0.83
Social adversity and regional differences in prescribing of ADHD medication for school-age children. J Dev Behav Pediatr (2015) 0.83
Use of antibiotics in children: a Danish nationwide drug utilization study. Pediatr Infect Dis J (2015) 0.83
Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals. Diabetologia (2014) 0.83
Therapy for obesity based on gastrointestinal hormones. Rev Diabet Stud (2011) 0.83
Hormone replacement therapy and risk of glioma: a nationwide nested case-control study. Cancer Epidemiol (2013) 0.83
Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures. Basic Clin Pharmacol Toxicol (2012) 0.83
Excessive anticoagulation with warfarin or phenprocoumon may have multiple causes. Dan Med J (2012) 0.82
Primary non-adherence in general practice: a Danish register study. Eur J Clin Pharmacol (2014) 0.82
Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes. Curr Opin Mol Ther (2010) 0.82
Hormonal contraceptive use and risk of glioma among younger women: a nationwide case-control study. Br J Clin Pharmacol (2015) 0.82
Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding. Obes Surg (2011) 0.82
Sustained weight loss after treatment with a glucagon-like peptide-1 receptor agonist in an obese patient with schizophrenia and type 2 diabetes. Am J Psychiatry (2013) 0.82
Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes. PLoS One (2013) 0.82
Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes. Regul Pept (2010) 0.81
Identifying admitted patients at risk of dying: a prospective observational validation of four biochemical scoring systems. BMJ Open (2013) 0.81
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits. BMC Med (2012) 0.81
Characteristics and drug utilization patterns for heavy users of prescription drugs among the elderly: a Danish register-based drug utilization study. Eur J Clin Pharmacol (2015) 0.81
Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus. BioDrugs (2008) 0.81
Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques. Exp Dermatol (2013) 0.81
Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans? J Clin Endocrinol Metab (2010) 0.81
Patients' concern about their medicine after a generic switch: a combined cross-sectional questionnaire and register study. Pharmacoepidemiol Drug Saf (2014) 0.81